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March 29, 2011:1496–500Although some diversity is evident in patterns of regional LV
systolic dysynergy (“ballooning”), each of the variants is similar to
the “classic” circumferential mid and apical LV dyskinesia with
sparing of the basal segment. Subclassifying and renaming this
cardiomyopathy according to specific LV contraction patterns
could lead to more confusion (11).
The broad clinical spectrum of this acute cardiomyopathy also
suggests that heterogeneous and multifactorial pathophysiologic
mechanisms and susceptibilities are involved, because no single
etiologic variable (e.g.,“stress,” sex, age) can account for all affected
patients (5–8,10–12). Imprecise nomenclature can impair a full
understanding of clinical profile, and it can influence investigation
into underlying mechanisms. Indeed, none of the proposed mech-
anisms—catecholamine excess and increased sympathetic tone,
epicardial coronary spasm or myocardial bridging, genetic status,
psychological factors, antidepressant drugs, hormonal influences,
endothelial or microvascular dysfunction, and myocardial stun-
ning—can explain all occurrences of this cardiomyopathy.
There is no universally accepted terminology or consensus for
the novel acute cardiomyopathy discussed here, now 20 years since
its appearance in published reports. Many commonly used terms,
such as “stress cardiomyopathy,” no longer accurately describe the
diverse clinical spectrum of this condition and consequently are
potentially misleading with respect to presentation, management,
and underlying pathophysiology. The popular (and original) term
“tako-tsubo cardiomyopathy,” which describes the unusual LV
contractile pattern, would seem the most appropriate and conve-
nient name—general enough to allow future clinical variants to be
included within this nomenclature, and with the advantage of
acknowledging Japanese investigators who were responsible for
ContinuedTable 1 Continued
Stress cardiomyopathy
Acute stress cardiomyopathy
Human stress cardiomyopathy
Acute & reversible cardiomyopathy provoked by stress
Stress-induced cardiomyopathy
Stress-induced takotsubo cardiomyopathy
Stress-induced apical ballooning syndrome
Stress-related left ventricular dysfunction
Stress-related cardiomyopathy
Stress-related cardiomyopathy syndrome
Stress takotsubo cardiomyopathy
Emotional stress-induced ampulla cardiomyopathy
Mid-ventricular stress cardiomyopathy
Atypical transient stress-induced cardiomyopathy
Stress-induced myocardial stunning
Emotional stress-induced tako-tsubo cardiomyopathy
Stress-associated catecholamine induced cardiomyopathy
Neurogenic stress syndrome
Other
Neurogenic stunned myocardium
Adrenergic cardiomyopathy
Broken heart syndrome
Ampulla cardiomyopathy
Ampulla-shaped cardiomyopathy
“Chestnut-shaped” transient regional left ventricular hypokinesia
Ball-shaped spherical dilation of left ventricular apex
The artichoke heart
Transient mid-ventricular akinesia
Transient antero-apical dyskinesiaits initial recognition and description.Scott W. Sharkey, MD
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Letters to the Editor
Common Variant on
Chromosome 9p21 Predicts
Severity of Coronary Artery Disease
We read with great interest the paper by Dandona et al. (1) and the
accompanying editorial commentary by Anderson and Horne (2),
published in a recent issue of the Journal. Dandona et al. (1)
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March 29, 2011:1496–500elegantly showed an association between a variant (SNP
rs1333049) on chromosome 9p21 and coronary artery disease
(CAD) severity represented by the number of coronary arteries
with 50% stenosis in 2 cohorts of CAD patients who did not
have diabetes mellitus (1). This provides novel evidence for an
influence on the extent of coronary arterial lesions by the 9p21
variant, which was identified recently by genome-wide association
studies to be a major genetic determinant that increases the risk of
CAD.
Interestingly, several previous studies did not find the association
between 9p21 and CAD severity defined by the number of coronary
arteries with significant stenosis (3–5). In their report, Dandona et al.
(1) speculated on several possible explanations, 1 of which is the
nclusion of CAD patients with diabetes mellitus in the previously
tudies, which might confound and obscure the effect of 9p21 on
AD.
To investigate this possibility, we undertook analyses in a cohort of
AD patients (mean age 63 years, n 1,094) recruited previously in
he SAS (Southampton Atherosclerosis Study) (6). The subjects had
50% stenosis in at least 1 major epicardial coronary artery and were
ll of European ancestry. When CAD patients with diabetes mellitus
n 146) were excluded, we observed an association between the risk
llele (C allele) of the 9p21 SNP rs1333049 and increased risk of
-vessel disease (3VD) defined by 50% stenosis in the 3 major
oronary arteries (p  0.022) (Fig. 1). Logistic regression analysis
howed that each copy of the risk allele was associated with a 30%
ncreased risk of 3VD (odds ratio: 1.30 [95% confidence interval: 1.04
o 1.63]) after adjusting for age, sex, smoking, hypertension, hyper-
holesterolemia, lipid-lowering treatment, and body mass index.
owever, when the CAD patients with diabetes mellitus were
ncluded in the analysis, the relationship between SNP rs1333049 and
AD severity became nonsignificant statistically (p  0.077). This
nding is in line with the possibility of an obscuring effect of diabetes
ellitus, suggested by Dandona et al. (1).
Thus, the results of our study support that there is an association
Figure 1 Association of 9p21 Genotype With Severity of CAD
Presented in the column chart are percentages of patients with 3-vessel dis-
ease (3VD) (n  223) as a function of genotype. The p value was derived from
logistic regression analysis with adjustment for age, sex, smoking, hyperten-
sion, hypercholesterolemia, lipid-lowering treatment, and body mass index.
Patients with diabetes mellitus were excluded. CAD  coronary artery disease.etween 9p21 and CAD severity, arguing for the notion that thep21 variant predisposes to initiation as well as progression of
AD (2). In addition, our data highlight the need for further
etailed studies to assess the effects of 9p21 on CAD phenotypes
nd its potential interactions with other cardiovascular risk factors
uch as diabetes mellitus.
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Reply
We thank Mr. Chan and colleagues for the interest in our paper
(1). They are able to replicate the association of gene dosage of the
risk variant located at 9p21 and severity of coronary artery disease
(CAD) in the SAS (Southampton Atherosclerosis Study) when
diabetic patients are excluded from their analysis. However, when
diabetic patients are included, this association no longer achieves
statistical significance. Given the findings of Doria et al. (2) that
poor glycemic control tended to amplify the risk association of
CAD with 9p21, we had postulated in our original paper that the
inability to demonstrate such an association in other cohorts might
potentially have been secondary to a confounding effect of diabetes
(1). The finding of Mr. Chan and colleagues would lend credence
to this hypothesis. We do recognize that further similar confirma-
tory studies are required. However, these findings do underscore
the need for meticulous phenotyping in genetic association studies.
Furthermore, it demonstrates the potential complex interplay
